LinkedIn: [alexandre-troullioud-lucas](http://www.linkedin.com/in/alexandre-troullioud-lucas-35644754)
Professional Role and Affiliations
Alexandre G. Troullioud Lucas, MD, MSc, serves as an Assistant Attending Pediatric Hematologist-Oncologist and is the Medical Director of the Pediatric Inpatient Unit at Memorial Sloan Kettering Cancer Center (MSKCC). He is a core member of the MSK Kids team, providing specialized care to children and young adults affected by cancer. His clinical focus is pediatric hematologic malignancies and oncologic diseases. He is also affiliated with Weill Cornell Medicine, where he completed clinical fellowships in Pediatric Hematology/Oncology.
Educational Background and Training
- Doctor of Medicine (MD), Leiden University Medical Center, Netherlands, 2012
- Master of Science (MSc), Biomedical Sciences, Leiden University Medical Center
- Pediatric residency completed at Lincoln Medical and Mental Health Center, Bronx, NY
- Postgraduate clinical fellowship training in Pediatric Hematology/Oncology at MSKCC/Weill Cornell Medicine
- Raised in the Netherlands, providing an international perspective in medical training
Clinical and Research Expertise
Dr. Troullioud Lucas specializes in pediatric hematologic oncology, with dedicated expertise in diagnosing and managing cancers in children and young adults. His work encompasses both clinical care and research, with scholarly contributions focused on:
- Imaging adjuvants in pediatric surgical oncology: He is involved in advancing the role of image-guided surgery techniques, including fluorescent and radioguided methods, to improve tumor localization and surgical precision for pediatric cancer patients. His research includes multiple publications on imaging in pediatric lymphoma and surgical oncology, reflecting a commitment to integrating advanced imaging modalities in clinical protocols.
- Participation in clinical and translational research concerning molecular diagnostics, immune recovery monitoring post-hematopoietic cell transplantation (HCT), and disease severity determinants in pediatric oncology contexts.
- Co-authorship on several peer-reviewed studies cited in major oncology and pediatric hematology literature, indicating recognized expertise in his field.
Research Contributions and Publications
- Authored or co-authored at least 9 scholarly works with 38 citations, including peer-reviewed articles on imaging techniques and pediatric oncology care.
- Contributions to “Pediatric Blood and Cancer” and research synapse repositories at MSKCC emphasize his involvement with innovative diagnostic imaging and treatment strategies in pediatric cancers.
- Collaborated on research developing AI models for cancer detection (notably breast cancer detection in association with City College of New York and MSKCC experts), suggesting exposure to interdisciplinary projects involving computational imaging technologies.
- Active contributor to studies addressing COVID-19 impacts on pediatric hematology/oncology patients, reflecting engagement with emergent healthcare challenges.
Professional Standing and Institutional Role
- Recognized as a Clinical Fellow and Academic Pediatric Oncologist at one of the world’s leading cancer centers, Memorial Sloan Kettering.
- Leads care coordination and inpatient clinical management as Medical Director of the Pediatric Inpatient Unit, underpinning his leadership responsibility within the hospital’s pediatric oncology division.
- Practicing pediatric hematologist-oncologist licensed and based in New York, affiliated with multiple top-tier healthcare institutions.
- Supports NIH Cancer Center Support grant P30 CA008748, highlighting an active role in federally supported cancer research initiatives.
Implications for Engagement
Dr. Troullioud Lucas’s role at the intersection of pediatric oncology clinical care and advanced imaging-driven surgical research positions him as a key stakeholder in technology adoption that enhances diagnostic or surgical precision. His leadership in inpatient pediatric oncology further emphasizes his involvement in clinical operations, patient outcomes, and potential adoption of innovations in imaging and treatment modalities. His international medical education and active research collaborations indicate openness to interdisciplinary approaches and emerging medical technologies.
This detailed profile enables a precision-focused approach addressing his clinical interests, leadership responsibilities, and research engagement within the pediatric hematology/oncology domain at Memorial Sloan Kettering Cancer Center.
